Cantor Fitzgerald Maintains Overweight on Nyxoah, Lowers Price Target to $6
Cantor Fitzgerald analyst Sarah James maintains Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $11 to $6.
Read original at benzingaStocks · News reference
Nyxoah Lowers FY2026 Sales Guidance from $42.156M-$46.840M to $41.852M-$46.502M vs $44.410M Est
Nyxoah (NASDAQ:NYXH) lowers FY2026 sales outlook from $42.156 million-$46.840 million to $41.852 million-$46.502 million vs $44.410 million estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 5, 2026, 9:00 PM
- Checked
- Aug 5, 2026, 9:00 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Piper Sandler Reiterates Overweight on Nyxoah, Lowers Price Target to $6
Piper Sandler analyst Adam Maeder reiterates Nyxoah (NASDAQ:NYXH) with a Overweight and lowers the price target from $7 to $6.
Read original at benzingaNyxoah Q2 EPS $(0.67) Misses $(0.47) Estimate, Sales $8.922M Miss $9.030M Estimate
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.47) by 42.55 percent. This is a 8.06 percent decrease over losses of $(0.62) per share from the same
Read original at benzinga